Read, Watch or Listen

New studies reveal a potential link between GLP-1 agonist drugs like Ozempic and Wegovy and a slightly increased risk of NAION, a rare eye condition causing vision loss. One study showed a modest risk increase, while another found no increased risk of NAION but a slight rise in diabetic retinopathy. However, overall, GLP-1 users experienced fewer sight-threatening complications. Patients with pre-existing conditions like high blood pressure or diabetes should discuss risks with their doctor before starting these medications. Regular eye exams are crucial for early detection of complications.

Prepared by Olivia Bennett and reviewed by editorial team.